1. |
Lazaro JL, Izzo V, Meaume S, et al. Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. J Wound Care, 2016, 25(5): 277-287.
|
2. |
Raffetto JD. Pathophysiology of wound healing and alterations in venous leg ulcers—review. Phlebology, 2016, 31(1 Suppl): 56-62.
|
3. |
Serra R, Amato B, Butrico L, et al. Study on the efficacy of surgery of the superficial venous system and of compression therapy at early stages of chronic venous disease for the prevention of chronic venous ulceration. Int Wound J, 2016, 13(6): 1385-1388.
|
4. |
Filkor K, Németh T, Nagy I, et al. The expression of inflammatory cytokines, TAM tyrosine kinase receptors and their ligands is upregulated in venous leg ulcer patients: a novel insight into chronic wound immunity. Int Wound J, 2016, 13(4): 554-562.
|
5. |
Harding KG, Vanscheidt W, Partsch H, et al. Adaptive compression therapy for venous leg ulcers: a clinically effective, patient-centred approach. Int Wound J, 2016, 13(3): 317-325.
|
6. |
Vivas A, Lev-Tov H, Kirsner RS. Venous leg ulcers. Ann Intern Med, 2016, 165(3): ITC17-ITC32.
|
7. |
Alavi A, Sibbald RG, Phillips TJ, et al. What’s new: Management of venous leg ulcers: Treating venous leg ulcers. J Am Acad Dermatol, 2016, 74(4): 643-664.
|
8. |
Raffetto JD. Pathophysiology of chronic venous disease and venous ulcers. Surg Clin North Am, 2018, 98(2): 337-347.
|
9. |
Shanmugam VK, Angra D, Rahimi H, et al. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord, 2017, 5(2): 280-292.
|
10. |
Tate S, Price A, Harding K. Dressings for venous leg ulcers. BMJ, 2018, 361: k1604.
|
11. |
Gohel MS, Heatley F, Liu X, et al. EVRA trial investigators. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med, 2018, 378(22): 2105-2114.
|
12. |
Morozov AM, Sherman RA. Survey of patients of the Tver region of Russia regarding maggots and maggot therapy. Int Wound J, 2019, 16(2): 401-405.
|
13. |
Nigam Y, Morgan C. Does maggot therapy promote wound healing? The clinical and cellular evidence. J Eur Acad Dermatol Venereol, 2016, 30(5): 776-782.
|
14. |
Andriessen A, Apelqvist J, Mosti G, et al. Compression therapy for venous leg ulcers: risk factors for adverse events and complications, contraindications—a review of present guidelines. J Eur Acad Dermatol Venereol, 2017, 31(9): 1562-1568.
|
15. |
De Caridi G, Massara M, Stilo F, et al. Effectiveness of prostaglandin E1 in patients with mixed arterial and venous ulcers of the lower limbs. Int Wound J, 2016, 13(5): 625-629.
|
16. |
Jull A, Slark J, Parsons J. Prescribed exercise with compression vs compression alone in treating patients with venous leg ulcers: A systematic review and meta-analysis. JAMA Dermatol, 2018, 154(11): 1304-1311.
|
17. |
Norman G, Westby MJ, Rithalia AD, et al. Dressings and topical agents for treating venous leg ulcers. Cochrane Database Syst Rev, 2018, (6): CD012583.
|
18. |
de Oliveira Carvalho PE, Magolbo NG, De Aquino RF, et al. Oral aspirin for treating venous leg ulcers. Cochrane Database Syst Rev, 2016, (2): CD009432.
|
19. |
Shields DA, Andaz SK, Sarin S, et al. Plasma elastase in venous disease. Br J Surg, 1994, 81(10): 1496-1499.
|
20. |
Evangelista MT, Casintahan MF, Villafuerte LL. Simvastatin as a novel therapeutic agent for venous ulcers: a randomized, double-blind, placebo-controlled trial. Br J Dermatol, 2014, 170(5): 1151-1157.
|
21. |
Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev, 2016, (4): CD003229.
|
22. |
Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev, 2015, (6): CD004123.
|
23. |
Dumville JC, Land L, Evans D, et al. Negative pressure wound therapy for treating leg ulcers. Cochrane Database Syst Rev, 2015, (7): CD011354.
|
24. |
Wang E, Tang R, Walsh N, et al. Topical negative pressure therapy and compression in the management of venous leg ulcers: a pilot study. WPR, 2017, 25(1): 36-40.
|
25. |
Kirsner RS, Baquerizo Nole KL, Fox JD, et al. Healing refractory venous ulcers: new treatments offer hope. J Invest Dermatol, 2015, 135(1): 19-23.
|
26. |
Marston W, Tang J, Kirsner RS, et al. Wound Healing Society 2015 update on guidelines for venous ulcers. Wound Repair Regen, 2016, 24(1): 136-144.
|
27. |
Charles CA, Tomic-Canic M, Vincek V, et al. A gene signature of nonhealing venous ulcers: potential diagnostic markers. J Am Acad Dermatol, 2008, 59(5): 758-771.
|
28. |
Maccatrozzo S, Onida S, Davies AH. Guidelines on venous ulceration: a mess. Phlebology, 2017, 32: 369-370.
|
29. |
Where Can I Find a Practice Guidelines? AGREE Enterprise Website. 2018. updated 2018. Available at: https://www.agreetrust.org.
|
30. |
Wittens C, Davies AH, Baekgaard N, et al. Editor’s choice e management of chronic venous disease: clinical practice guidelines of the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg, 2015, 49(6): 678-737.
|
31. |
Couch KS, Corbett L, Gould L, et al. The international consolidated venous ulcer guideline update 2015: process improvement, evidence analysis, and future goals. Ostomy Wound Manage, 2017, 63(5): 42-46.
|
32. |
SIGN Network. SIGN guideline 120: management of chronic venous leg ulcers. Available at: https://www.sign.ac.uk/sign-120-managementof-chronic-venous-leg-ulcers.html.
|
33. |
Schünemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2. 0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ, 2014, 186(3): E123-E142.
|
34. |
Abelyan G, Abrahamyan L, Yenokyan G. A case-control study of risk factors of chronic venous ulceration in patients with varicose veins. Phlebology, 2018, 33(1): 60-67.
|
35. |
Jockenhöfer F, Gollnick H, Herberger K, et al. Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany. Int Wound J, 2016, 13(5): 821-828.
|
36. |
Smith D, Team V, Barber G, et al. Factors associated with physical activity levels in people with venous leg ulcers: A multicentre, prospective, cohort study. Int Wound J, 2018, 15(2): 291-296.
|
37. |
Kelly M, Gethin G. Prevalence of chronic illness and risk factors for chronic illness among patients with venous leg ulceration: A cross-sectional study. Int J Low Extrem Wounds, 2019, 18(3): 301-308.
|
38. |
Shirakata Y, Kimura R, Nanba D, et al. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci, 2005, 118(Pt 11): 2363-2370.
|
39. |
Phillips P, Lumley E, Duncan R, et al. A systematic review of qualitative research into people’s experiences of living with venous leg ulcers. J Adv Nurs, 2018, 74(3): 550-563.
|
40. |
Nuss CA, Huegel J, Finkielsztein, et al. Liquid poly-N-acetyl glucosamine (sNAG) improves achilles tendon healing in a rat model. Ann Biomed Eng, 2021, 49(2): 515-522.
|
41. |
Mosmiller LT, Steele KN, Shrader CD, et al. Evaluation of inflammatory cell biomarkers in chronic venous insufficiency. Phlebology, 2017, 32(9): 634-640.
|
42. |
Scholl L, Dörler M, Stücker M. Ulcers in obesity-associated chronic venous insufficiency. Hautarzt, 2017, 68(7): 560-565.
|
43. |
Suehiro K, Morikage N, Yamashita O, et al. Risk factors in patients with venous stasis-related skin lesions without major abnormalities on duplex ultrasonography. Ann Vasc Dis, 2016, 9(3): 201-204.
|
44. |
Lattimer CR, Franceschi C, Kalodiki E. Optimizing calf muscle pump function. Phlebology, 2018, 33(5): 353-360.
|
45. |
Jeong Y, Heo S, Lee G, et al. Pre-obesity and obesity impacts on passive joint range of motion. Ergonomics, 2018, 61(9): 1223-1231.
|
46. |
Bullock VE, Griffiths P, Sherar LB, et al. Sitting time and obesity in a sample of adults from Europe and the USA. Ann Hum Biol, 2017, 44(3): 230-236.
|
47. |
Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg, 2016, 63(2 Suppl): 3S-21S.
|